EIF2B4 and leukodystrophy: A commercial molecular panel for leukodystrophies by NGS sequencing identified the variant c.725C>T (NM_015636.3; p.Pro242Leu) in the EIF2B4 gene in a homozygous state, a variant previously classified as likely pathogenic, confirming the diagnosis of VWMD with fibrodysplasia ossificans progressiva (FOP) or ovarioleukodystrophy.